Honokiol Alleviates Hypertrophic Scar by Targeting Transforming Growth Factor-β/Smad2/3 Signaling Pathway

Overview

Journal Front Pharmacol

Date 2017 May 5

PMID 28469575

Citations 15

Authors

Danyang Zhao

Yu Wang

Chao Du

Shengzhou Shan

Yifan Zhang

Zijing Du

Dong Han

Affiliations

Soon will be listed here.

Abstract

Hypertrophic scar (HPS) presents as excessive extracellular matrix deposition and abnormal function of fibroblasts. However, there is no single satisfactory method to prevent HPS formation so far. Here, we found that honokiol (HKL), a natural compound isolated from Magnolia tree, had an inhibitory effect on HPS both and . Firstly, HKL could dose-dependently down-regulate the mRNA and protein levels of type I collagen, type III collagen, and α-smooth muscle actin (α-SMA) in hypertrophic scar-derived fibroblasts (HSFs). Secondly, HKL suppressed the proliferation, migration abilities of HSFs and inhibited HSFs activation to myofibroblasts, but had no effect on cell apoptosis. Besides, the rabbit ear scar model further affirmed the inhibitory effects of HKL on collagen deposition, proliferating cell nuclear antigen and α-SMA. Finally, Western blot results showed that HKL reduced the phosphorylation status of Smad2/3, as well as affected the protein levels of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase1. Taken together, this study demonstrated that HKL alleviated HPS by suppressing fibrosis-related molecules and inhibiting HSFs proliferation, migration as well as activation to myofibroblasts via Smad-dependent pathway. Therefore, HKL could be used as a potential agent for treating HPS and other fibrotic diseases.

Citing Articles

Fraxinellone-mediated targeting of cathepsin B leakage from lysosomes induces ferroptosis in fibroblasts to inhibit hypertrophic scar formation.

Xu W, Lv H, Xue Y, Shi X, Fu S, Li X Biol Direct. 2025; 20(1):17.

PMID: 39905520 PMC: 11796038. DOI: 10.1186/s13062-025-00610-5.

Exosome Derived from Mesenchymal Stem Cells Alleviates Pathological Scars by Inhibiting the Proliferation, Migration and Protein Expression of Fibroblasts via Delivering miR-138-5p to Target SIRT1.

Zhao W, Zhang R, Zang C, Zhang L, Zhao R, Li Q Int J Nanomedicine. 2022; 17:4023-4038.

PMID: 36105616 PMC: 9467851. DOI: 10.2147/IJN.S377317.

TSG-6 inhibits hypertrophic scar fibroblast proliferation by regulating IRE1α/TRAF2/NF-κB signalling.

Ma L, Hua L, Yu W, Ke L, Li L Int Wound J. 2022; 20(4):1008-1019.

PMID: 36056472 PMC: 10031217. DOI: 10.1111/iwj.13950.

The application prospects of honokiol in dermatology.

Li Y, Liang C, Zhou X Dermatol Ther. 2022; 35(8):e15658.

PMID: 35726011 PMC: 9541939. DOI: 10.1111/dth.15658.

Honokiol Inhibits Atrial Metabolic Remodeling in Atrial Fibrillation Through Sirt3 Pathway.

Liu G, Xu W, Zang Y, Lou Q, Hang P, Gao Q Front Pharmacol. 2022; 13:813272.

PMID: 35370645 PMC: 8970047. DOI: 10.3389/fphar.2022.813272.

References

Chiang C, Sheu M, Lin Y, Wu C, Yang C, Chen M . Honokiol ameliorates renal fibrosis by inhibiting extracellular matrix and pro-inflammatory factors in vivo and in vitro. Br J Pharmacol. 2011; 163(3):586-97. PMC: 3101620. DOI: 10.1111/j.1476-5381.2011.01242.x. View

Chalmers R . The evidence for the role of transforming growth factor-beta in the formation of abnormal scarring. Int Wound J. 2011; 8(3):218-23. PMC: 7950816. DOI: 10.1111/j.1742-481X.2011.00771.x. View

Chrysanthopoulou A, Mitroulis I, Apostolidou E, Arelaki S, Mikroulis D, Konstantinidis T . Neutrophil extracellular traps promote differentiation and function of fibroblasts. J Pathol. 2014; 233(3):294-307. DOI: 10.1002/path.4359. View

Wang X, Kravchuk O, Winterford C, Kimble R . The correlation of in vivo burn scar contraction with the level of α-smooth muscle actin expression. Burns. 2011; 37(8):1367-77. DOI: 10.1016/j.burns.2011.07.018. View

Pillai V, Samant S, Sundaresan N, Raghuraman H, Kim G, Bonner M . Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3. Nat Commun. 2015; 6:6656. PMC: 4441304. DOI: 10.1038/ncomms7656. View

Li H, Yang L, Zhang Y, Gao Z . Kaempferol inhibits fibroblast collagen synthesis, proliferation and activation in hypertrophic scar via targeting TGF-β receptor type I. Biomed Pharmacother. 2016; 83:967-974. DOI: 10.1016/j.biopha.2016.08.011. View

Zurada J, Kriegel D, Davis I . Topical treatments for hypertrophic scars. J Am Acad Dermatol. 2006; 55(6):1024-31. DOI: 10.1016/j.jaad.2006.03.022. View

Xiao Z, Zhang J, Peng X, Dong Y, Jia L, Li H . The Notch γ-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway activation. Int J Biochem Cell Biol. 2014; 55:65-71. DOI: 10.1016/j.biocel.2014.08.009. View

Choi M, Ding Y, Kim S . TGF-β signaling via TAK1 pathway: role in kidney fibrosis. Semin Nephrol. 2012; 32(3):244-52. PMC: 3407377. DOI: 10.1016/j.semnephrol.2012.04.003. View

10.

Pohlers D, Brenmoehl J, Loffler I, Muller C, Leipner C, Schultze-Mosgau S . TGF-beta and fibrosis in different organs - molecular pathway imprints. Biochim Biophys Acta. 2009; 1792(8):746-56. DOI: 10.1016/j.bbadis.2009.06.004. View

11.

Page-McCaw A, Ewald A, Werb Z . Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007; 8(3):221-33. PMC: 2760082. DOI: 10.1038/nrm2125. View

12.

Chen Y, Tsai K, Chan D, Lan K, Chen C, Yang R . Honokiol, a low molecular weight natural product, prevents inflammatory response and cartilage matrix degradation in human osteoarthritis chondrocytes. J Orthop Res. 2013; 32(4):573-80. DOI: 10.1002/jor.22577. View

13.

Zhang Y, Zhou S, Cheng X, Yi B, Shan S, Wang J . Baicalein attenuates hypertrophic scar formation via inhibition of the transforming growth factor-β/Smad2/3 signalling pathway. Br J Dermatol. 2015; 174(1):120-30. DOI: 10.1111/bjd.14108. View

14.

Arpino V, Brock M, Gill S . The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol. 2015; 44-46:247-54. DOI: 10.1016/j.matbio.2015.03.005. View

15.

Ehrlich H, Desmouliere A, Diegelmann R, Cohen I, Compton C, Garner W . Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol. 1994; 145(1):105-13. PMC: 1887298. View

16.

Beanes S, Dang C, Soo C, Ting K . Skin repair and scar formation: the central role of TGF-beta. Expert Rev Mol Med. 2004; 5(8):1-22. DOI: 10.1017/S1462399403005817. View

17.

Armour A, Scott P, Tredget E . Cellular and molecular pathology of HTS: basis for treatment. Wound Repair Regen. 2008; 15 Suppl 1:S6-17. DOI: 10.1111/j.1524-475X.2007.00219.x. View

18.

Zhang Q, Zhao W, Ye C, Zhuang J, Chang C, Li Y . Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis. Oncotarget. 2015; 6(35):37335-48. PMC: 4741933. DOI: 10.18632/oncotarget.6135. View

19.

Kim K, Park K, Chun K, Chung W . Honokiol inhibits the progression of collagen-induced arthritis by reducing levels of pro-inflammatory cytokines and matrix metalloproteinases and blocking oxidative tissue damage. J Pharmacol Sci. 2010; 114(1):69-78. DOI: 10.1254/jphs.10070fp. View

20.

Zhang Y, Shan S, Wang J, Cheng X, Yi B, Zhou J . Galangin inhibits hypertrophic scar formation via ALK5/Smad2/3 signaling pathway. Mol Cell Biochem. 2016; 413(1-2):109-18. DOI: 10.1007/s11010-015-2644-3. View